Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 5
1963 4
1964 3
1965 6
1966 6
1967 5
1968 4
1969 5
1970 1
1971 2
1973 3
1974 2
1975 2
1976 5
1977 4
1978 4
1979 6
1980 6
1981 2
1982 7
1983 9
1984 8
1985 10
1986 18
1987 8
1988 15
1989 12
1990 6
1991 17
1992 16
1993 31
1994 21
1995 25
1996 24
1997 24
1998 17
1999 30
2000 25
2001 26
2002 29
2003 26
2004 29
2005 34
2006 24
2007 35
2008 32
2009 31
2010 42
2011 66
2012 65
2013 43
2014 51
2015 40
2016 38
2017 59
2018 44
2019 56
2020 57
2021 70
2022 77
2023 69
2024 69
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,397 results

Results by year

Filters applied: . Clear all
Page 1
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
Okada-Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami K, Matsuda K, Yamaguchi M, Tanabe H, Kimura-Someya T, Shirouzu M, Ogata H, Tokuyama K, Ueki K, Nagano T, Tanaka A, Yokoyama S, Kadowaki T. Okada-Iwabu M, et al. Among authors: nagano t. Nature. 2013 Nov 28;503(7477):493-9. doi: 10.1038/nature12656. Epub 2013 Oct 30. Nature. 2013. PMID: 24172895
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N; J-Land 3S Study Group. Kakihana Y, et al. Among authors: nagano t. Lancet Respir Med. 2020 Sep;8(9):863-872. doi: 10.1016/S2213-2600(20)30037-0. Epub 2020 Mar 31. Lancet Respir Med. 2020. PMID: 32243865 Clinical Trial.
Novel cancer therapy targeting microbiome.
Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y. Nagano T, et al. Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190864 Free PMC article. Review.
Microbiome as a Target for Cancer Therapy.
Suraya R, Nagano T, Kobayashi K, Nishimura Y. Suraya R, et al. Among authors: nagano t. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420920721. doi: 10.1177/1534735420920721. Integr Cancer Ther. 2020. PMID: 32564632 Free PMC article. Review.
Parental-to-embryo switch of chromosome organization in early embryogenesis.
Collombet S, Ranisavljevic N, Nagano T, Varnai C, Shisode T, Leung W, Piolot T, Galupa R, Borensztein M, Servant N, Fraser P, Ancelin K, Heard E. Collombet S, et al. Among authors: nagano t. Nature. 2020 Apr;580(7801):142-146. doi: 10.1038/s41586-020-2125-z. Epub 2020 Mar 25. Nature. 2020. PMID: 32238933
1,397 results